The Expert Breast Cancer Panel of the National Comprehensive Cancer Network (NCCN) met July 10-12, 2011 in Philadelphia, PA. At the meeting, the multidisciplinary breast cancer experts voted in favor of maintaining the current position and recommendation in the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer on the use of bevacizumab in metastatic breast cancer.
More...
Linear Mode
